Research Article Details

Article ID: A08528
PMID: 32073443
Source: Eur J Gastroenterol Hepatol
Title: The association of nonalcoholic steatohepatitis and hepatocellular carcinoma.
Abstract: BACKGROUND: Current guidelines recommend surveillance for hepatocellular carcinoma (HCC) in high-risk patients. This high risk is defined by the presence of cirrhosis. However, HCC due to underlying nonalcoholic steatohepatitis (NASH), even without progressing to cirrhosis, is a rising concern. Hence, we aimed to determine the association of HCC with NASH using a large national database. METHODS: A cross-sectional study was performed using the 2012 National Inpatient Sample. The study group was all adult patients' age 18-90&#8201;years who have a diagnosis of NASH which was identified using the International Classification of Diseases 9th version (ICD-9) codes. The control group included the rest of adult individuals without discharge records of NASH. We identified the diagnosis of HCC in both study and control groups using the ICD-9 codes. We calculated the association between NASH and HCC using univariable and multivariate logistic regression. RESULTS: Totally, 30&#8201;712&#8201;524 hospitalizations were included in our study. This cohort included 218&#8201;950 patients with NASH (study group) and 30&#8201;493&#8201;574 patients without NASH (control group). The study group patients aged 57.3&#8201;&#177;&#8201;0.10&#8201;years (59.4% females) comparing to 54.5&#8201;&#177;&#8201;0.11&#8201;years (57.1% female) in the control group. HCC prevalence in subjects with NASH was 0.50% [95% confidence interval (CI): 0.41-0.59] compared to 0.21% (95% CI: 0.20-0.23) in subjects without NASH (P&#8201;<&#8201;0.001). After adjusting for age, gender, smoking, alcohol use, obesity, hepatitis C virus, hepatitis B virus, hemochromatosis, HIV, cirrhosis and the modified comorbidity index, subjects with NASH were 60% more likely to have HCC than those without NASH (adjusted odds ratio: 1.6, 95% CI: 1.4-1.9, P&#8201;<&#8201;0.001). CONCLUSION: Our study showed that NASH patients are 60% more likely to develop HCC compared with patients without NASH. Close monitoring and even periodical surveillance might be needed.
DOI: 10.1097/MEG.0000000000001681